Global venture capital firm with a focus on early and growth-stage technology companies.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| E2D | 2024 | Grant | Undisclosed | Davidson |
| e6data | 2024 | Series A | $10.0M | College Station |
| Syntax Health | 2024 | Seed | $25K | Atlanta |
| Ayble Health | 2024 | Seed | $25K | Boston |
| Applied Bioplastics | 2024 | Convertible Note | Undisclosed | Austin |
| Momo Medical | 2024 | Series Unknown | $8.9M | Delft |
| Architect Health | 2024 | Pre-Seed | $25K | New York |
| Artiwise | 2024 | Seed | $750K | Sariyer |
| Sanarai | 2024 | Grant | $250K | Chicago |
| Dharaksha Ecosolutions | 2024 | Seed | $3.0M | New Delhi |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1326 | E2D | Grant | Undisclosed | Davidson, United States |
| 1327 | e6data | Series A | $10.0M | College Station, United States |
| 1328 | Syntax Health | Seed | $25K | Atlanta, United States |
| 1329 | Ayble Health | Seed | $25K | Boston, United States |
| 1330 | Applied Bioplastics | Convertible Note | Undisclosed | Austin, United States |
| 1331 | Momo Medical | Series Unknown | $8.9M | Delft, The Netherlands |
| 1332 | Architect Health | Pre-Seed | $25K | New York, United States |
| 1333 | Artiwise | Seed | $750K | Sariyer, Turkey |
| 1334 | Sanarai | Grant | $250K | Chicago, United States |
| 1335 | Dharaksha Ecosolutions | Seed | $3.0M | New Delhi, India |
E2D is a non-profit organization creating solutions to provide home-based digital access.
e6data develops Lakehouse compute engines designed for enterprise-level data analytics.
Syntax Health is an enterprise SaaS-based solution for health organisations and providers aimed at expediting value-based care alignment.
Ayble is a clinically-backed digital health platform that provides holistic care for people with GI conditions.
Applied Bioplastics manufactures bioplastics in retail, packaging, and medical industries to improve plastic recycling.
Momo Medical develops an IoT-equipped bed sensor that helps nurses track their elderly patients.
AI-powered vendor management platform that helps payers evaluate, procure, and monitor digital health to relieve point-solution fatigue.
Artiwise is a digital technology firm that offers a cloud-based data analytics platform to transform text data and voice recordings.
Sanarai is a mental health online platform for the Latino community.
Dharaksha Ecosolutions is a Packaging and Containers Manufacturing company.
Empiraa is a SaaS that helps organizations to become organize and strategize.
Moneyview is a provider of a credit platform that offers loans and financial management tools.
LignEasy is a low-impact, sulfuric acid-free lignin recovery solution for pulp mills.
Morphotonics is a provider of nanoimprint and microreplication technology solution.
The Leading Hands-on Lab Platform in Future Networks
Chicory is a technology company that connects recipe ingredients.
reOrbital is the world’s first mass microgravity manufacturer.
Enabling Real-time Data Feeds from Existing and New EO Satellites
MOTH: is a beverages company that provides ready-to-drink cocktail for family and friends.
Eartheye Space solves accessibilty, affordability and usabillty issues with geospatial data.
Yune offers digital care label B2B solutions to assist brands in the fashion industry.
Piccolo is an organic baby food range and guaranteed to tickle tiny tastebuds.
The Gut Stuff offers online health tips and fiber chocolates.
Fearne & Rosie produces a range of jams, honey and spreads, with its products listed in Waitrose, Ocado and Morrisons.
Roboligent offers a robot that provides automated physical therapy exercises for patients.
Accel has invested in 3,802 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Accel's top investment sectors include Health Care, Software, Analytics, SaaS, Manufacturing. The firm invests across 56 different industry categories.
Among tracked funding rounds, Morphotonics received $11.0M in a Series B round. Accel's total known invested capital is $81.8B.
Accel's average investment size is $178.1M across its portfolio of 3,802 companies.
Recent Accel portfolio additions include E2D, e6data, Syntax Health, Ayble Health, Applied Bioplastics. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors